Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Viatris (VTRS)

Viatris Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VTRS
DateTimeSourceHeadlineSymbolCompany
07/06/202411:59PR Newswire (US)Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:VTRSViatris Inc
04/06/202411:59PR Newswire (US)Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:VTRSViatris Inc
03/06/202412:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTRSViatris Inc
03/06/202411:59PR Newswire (US)Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of DirectorsNASDAQ:VTRSViatris Inc
31/05/202411:59PR Newswire (US)Viatris to Participate in the Jeffries Global Healthcare ConferenceNASDAQ:VTRSViatris Inc
28/05/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
28/05/202421:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTRSViatris Inc
21/05/202411:59PR Newswire (US)Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at ScaleNASDAQ:VTRSViatris Inc
09/05/202412:47IH Market NewsU.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25%NASDAQ:VTRSViatris Inc
09/05/202412:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTRSViatris Inc
09/05/202411:59PR Newswire (US)Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance RangesNASDAQ:VTRSViatris Inc
02/05/202422:00PR Newswire (US)Viatris to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:VTRSViatris Inc
01/05/202411:59PR Newswire (US)Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental HealthNASDAQ:VTRSViatris Inc
16/04/202421:30PR Newswire (US)Viatris to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:VTRSViatris Inc
15/04/202413:00PR Newswire (US)Viatris Appoints Corinne Le Goff as Chief Commercial OfficerNASDAQ:VTRSViatris Inc
15/04/202411:59PR Newswire (Canada)Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in CanadaNASDAQ:VTRSViatris Inc
15/04/202411:59PR Newswire (Canada)Viatris annonce le lancement de la première version générique bioéquivalente du Copaxone [MD] 20 mg/mL au CanadaNASDAQ:VTRSViatris Inc
01/04/202411:59PR Newswire (US)Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United StatesNASDAQ:VTRSViatris Inc
27/03/202410:59PR Newswire (US)Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its PipelineNASDAQ:VTRSViatris Inc
06/03/202401:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
06/03/202401:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
06/03/202401:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
06/03/202400:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
06/03/202400:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
06/03/202400:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
04/03/202423:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTRSViatris Inc
28/02/202412:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTRSViatris Inc
28/02/202411:30PR Newswire (US)Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial GuidanceNASDAQ:VTRSViatris Inc
28/02/202406:00PR Newswire (US)Viatris and Idorsia Enter Into Significant Global Research and Development CollaborationNASDAQ:VTRSViatris Inc
23/02/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
 Showing the most relevant articles for your search:NASDAQ:VTRS